Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Protective Effect of Valsartan on Beleomycine-Induced Fibrosis

Hoda Mojiri Forushani 1 , Ali Asghar Hemmati 1 , * , Ali Khodadadi 2 , Mohammad-Ali Assarehzadegan 3 and Mohammad Rashno 2
Authors Information
1 Pharmacology Department ,School of Pharmacy and Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Immunology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran
3 Immunology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 2017, 12 (1); e33973
  • Published Online: September 4, 2016
  • Article Type: Research Article
  • Received: November 7, 2015
  • Revised: May 13, 2016
  • Accepted: May 29, 2016
  • DOI: 10.5812/jjnpp.33973

To Cite: Mojiri Forushani H, Hemmati A A, Khodadadi A, Assarehzadegan M, Rashno M. Protective Effect of Valsartan on Beleomycine-Induced Fibrosis, Jundishapur J Nat Pharm Prod. 2017 ; 12(1):e33973. doi: 10.5812/jjnpp.33973.

Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61(11): 980-5[DOI][PubMed]
  • 2. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res. 2002; 3: 3[PubMed]
  • 3. Green FH. Overview of pulmonary fibrosis. Chest. 2002; 122(6 Suppl): 334-9[PubMed]
  • 4. Ozyurt H, Sogut S, Yildirim Z, Kart L, Iraz M, Armutcu F, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta. 2004; 339(1-2): 65-75[PubMed]
  • 5. Pardo A, Ruiz V, Arreola JL, Ramirez R, Cisneros-Lira J, Gaxiola M, et al. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. Am J Respir Crit Care Med. 2003; 167(6): 925-32[DOI][PubMed]
  • 6. Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Diez-Freire C, Dooies A, et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2010; 182(8): 1065-72[DOI][PubMed]
  • 7. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004; 286(1)-64[DOI][PubMed]
  • 8. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med. 2000; 161(6): 1999-2004[DOI][PubMed]
  • 9. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol. 2002; 282(4): 713-8[DOI][PubMed]
  • 10. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol. 2003; 163(6): 2523-30[DOI][PubMed]
  • 11. Molteni A. Editorial Part-II: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update. Curr Pharm Des. 2007; 13(13): 1295-8[PubMed]
  • 12. Couluris M, Kinder BW, Xu P, Gross-King M, Krischer J, Panos RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 2012; 190(5): 523-7[DOI][PubMed]
  • 13. Black HR, Bailey J, Zappe D, Samuel R. Valsartan: more than a decade of experience. Drugs. 2009; 69(17): 2393-414[DOI][PubMed]
  • 14. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986; 125(1): 97-106[PubMed]
  • 15. Woessner JFJ. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93: 440-7[PubMed]
  • 16. Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci. 2001; 322(4): 213-21[PubMed]
  • 17. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax. 2004; 59(1): 31-8[PubMed]
  • 18. Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res. 1997; 81(5): 804-11[PubMed]
  • 19. Ito H, Takemori K, Suzuki T. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens. 2001; 19(3 Pt 2): 591-7[PubMed]
  • 20. Uhal BD, Wang R, Laukka J, Zhuang J, Soledad-Conrad V, Filippatos G. Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacol Toxicol. 2003; 92(2): 81-7[PubMed]
  • 21. Molina-Molina M, Serrano-Mollar A, Bulbena O, Fernandez-Zabalegui L, Closa D, Marin-Arguedas A, et al. Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis. Thorax. 2006; 61(7): 604-10[DOI][PubMed]
  • 22. Long X, Xiong SD, Xiong WN, Xu YJ, Zhang ZX, Cao Y, et al. Losartan inhibited angiotensin induced human lung fibroblast transformation and collagen synthesis [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2007; 30(4): 273-8[PubMed]
  • 23. Yao HW, Zhu JP, Zhao MH, Lu Y. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration. 2006; 73(2): 236-42[DOI][PubMed]
  • 24. Ghazi-Khansari M, Mohammadi-Karakani A, Sotoudeh M, Mokhtary P, Pour-Esmaeil E, Maghsoud S. Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats. J Appl Toxicol. 2007; 27(4): 342-9[DOI][PubMed]
  • 25. Marut W, Kavian N, Servettaz A, Hua-Huy T, Nicco C, Chereau C, et al. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade. Arthritis Rheum. 2013; 65(5): 1367-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments